Sam Lubner

Sam Lubner

University of Wisconsin-Madison

H-index: 23

North America-United States

About Sam Lubner

Sam Lubner, With an exceptional h-index of 23 and a recent h-index of 18 (since 2020), a distinguished researcher at University of Wisconsin-Madison, specializes in the field of Oncology, Medical Oncology, Medical Education.

His recent articles reflect a diverse array of research interests and contributions to the field:

Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.

Actionable molecular alterations in veterans with advanced cholangiocarcinoma.

Latinas in medicine: evaluating and understanding the experience of Latinas in medical education: a cross sectional survey

Precision medicine in colorectal cancer: the molecular profile alters treatment strategies (vol 7, pg 252, 2015)

Survival impact of homologous recombination deficiency in veterans with cholangiocarcinoma including mutual exclusivity with pathogenic KRAS and TP53.

Corrigendum to “Precision medicine in colorectal cancer: the molecular profile alters treatment strategies”

Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer

Development of a palliative care lecture series for hematology-oncology fellows.

Sam Lubner Information

University

Position

Carbone Cancer Center

Citations(all)

3004

Citations(since 2020)

2148

Cited By

1559

hIndex(all)

23

hIndex(since 2020)

18

i10Index(all)

37

i10Index(since 2020)

28

Email

University Profile Page

University of Wisconsin-Madison

Google Scholar

View Google Scholar Profile

Sam Lubner Skills & Research Interests

Oncology

Medical Oncology

Medical Education

Top articles of Sam Lubner

Title

Journal

Author(s)

Publication Date

Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.

Mustafa Basree

Jacob Witt

Sharon M Weber

Nataliya Volodymyrivna Uboha

Rebecca Minter

...

2024/1/20

Actionable molecular alterations in veterans with advanced cholangiocarcinoma.

Ethan Samuel Lin

Eric G Mehlhaff

Colin P Bergstrom

Dyan M Lesnik

Noelle K LoConte

...

2024/1/20

Latinas in medicine: evaluating and understanding the experience of Latinas in medical education: a cross sectional survey

BMC Medical Education

Gabriella Geiger

Lauren Kiel

Miki Horiguchi

Celia Martinez-Aceves

Kelly Meza

...

2024/1/3

Precision medicine in colorectal cancer: the molecular profile alters treatment strategies (vol 7, pg 252, 2015)

Nguyen H Tran

Ludimila L Cavalcante

Sam J Lubner

Daniel L Mulkerin

Noelle K LoConte

...

2015/9

Survival impact of homologous recombination deficiency in veterans with cholangiocarcinoma including mutual exclusivity with pathogenic KRAS and TP53.

Colin P Bergstrom

Ethan Samuel Lin

Eric G Mehlhaff

Dyan M Lesnik

Noelle K LoConte

...

2024/1/20

Corrigendum to “Precision medicine in colorectal cancer: the molecular profile alters treatment strategies”

NH Tran

LL Cavalcante

SJ Lubner

2024

Spatial Alignment of Organoids Tracking Subclonal Chemotherapy Resistance in Pancreatic and Ampullary Cancer

Bioengineering

Md Shahadat Hossan

Ethan Samuel Lin

Eleanor Riedl

Austin Stram

Eric Mehlhaff

...

2023/1/10

Development of a palliative care lecture series for hematology-oncology fellows.

Rachel Rodenbach

Sam Joseph Lubner

Sara Johnson

2023/6/1

Neoadjuvant Stereotactic MR-Guided Ablative Radiation Therapy (SMART) and Surgical Outcomes in Patients with Pancreatic Cancer

International Journal of Radiation Oncology, Biology, Physics

H Menon

BA Morris

BJ Eckelmann

S Weber

SM Ronnekleiv-Kelly

...

2023/10/1

Long-term follow-up results of ipilimumab and nivolumab for the treatment of mismatch repair deficient locally advanced rectal cancer.

Danny Trotier

Nataliya Volodymyrivna Uboha

Kristina A Matkowskyj

Wei Zhang

Jeremy D Kratz

...

2023/6/1

Mentorship experiences are not all the same: a survey study of oncology trainees and early-career faculty

JCO oncology practice

Dame Idossa

Ana I Velazquez

Miki Horiguchi

Julia Alberth

Inas Abuali

...

2023/9

Advancing the Clinician Educator Career Pathway in Oncology

JCO Oncology Practice

Meredith Elana Giuliani

Nishin A Bhadkamkar

Eleni Giannopoulos

Sam Lubner

Jennifer Tseng

...

2023/5

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial

The Oncologist

Shannon Stockton

Paul Catalano

Steven J Cohen

Barbara A Burtness

Edith P Mitchell

...

2023/9/1

Tracking cancer stem cell expression of pancreatic and ampullary cancer organoids in response to chemotherapy

Cancer Research

Eleanor Riedl

Austin Stram

MD Shahadat Hossan

Ethan S Lin

Luke Koeppel

...

2023/4/4

Carboplatin and paclitaxel chemoradiation for localized anal cancer in patients not eligible for mitomycin and 5-fluorouracil.

Alyssa DeZeeuw

Patrick Thomas Grogan

Kayla Lemmon

Jenna Wilke

Anica Bausch

...

2023/6/1

Phase Ib of pembrolizumab (pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver oligometastatic MMR-proficient (pMMR) colorectal cancer (CRC …

Dustin A Deming

Sam Joseph Lubner

Nataliya Volodymyrivna Uboha

Philip Emmerich

Sean Kraus

...

2023/2/1

High rates of detection of metastatic/recurrent colorectal cancer on clinical imaging at the time of molecular residual disease testing following operative management.

Danny Trotier

Kayla Lemmon

Danielle Golner

Maddie Buratti

Alyssa DeZeeuw

...

2023/6/1

Prognostic impact of common pathologic alterations in pancreatic ductal adenocarcinoma from the veterans health administration.

Eric Glenn Mehlhaff

Syed Nabeel Zafar

Dyan M Lesnik

Noelle K LoConte

Sam Joseph Lubner

...

2022/1/5

Are we doing it right? Mentorship challenges for oncology fellows and early-career faculty from backgrounds underrepresented in medicine.

Dame Idossa

Ana I Velazquez Manana

Miki Horiguchi

Julia Alberth

Inas Abuali

...

2022/6/1

BTCRC-GI20-457: A phase II study of atezolizumab and bevacizumab in Child-Pugh B7 hepatocellular carcinoma (the AB7 Trial).

Kristen Renee Spencer

Anita Ahmed Turk

Shikha Jain

Kelsey Klute

Sam Joseph Lubner

...

2022/1/5

See List of Professors in Sam Lubner University(University of Wisconsin-Madison)